Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Hong

Showing results (1191-1200 of 1,220) with videos related to

Pageof 122
Sort By:
EMBO Reports|March 2, 2018
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancerXiu-Fei Chen, Meng-Xin Tian, Ren-Qiang Sun, et al.
JAMA Oncology|December 30, 2020
Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical TrialJunji Zhang, Yuqian Zhao, Yi Dai, et al.
Environmental Microbiology|November 19, 2013
Halomonas sulfidaeris-dominated microbial community inhabits a 1.8 km-deep subsurface Cambrian Sandstone reservoirYiran Dong, Charu Gupta Kumar, Nicholas Chia, et al.
Clinical and Translational Medicine|May 13, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancerChen Liang, Mu Ye, Lei Yu, et al.
Hepatology (Baltimore, Md.)|January 6, 2015
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progressionJia-Bin Cai, Guo-Ming Shi, Zhao-Ru Dong, et al.
Cancer Medicine|July 16, 2019
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trialFeng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Cancer Epidemiology|March 2, 2012
A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in ChinaFang-Hui Zhao, Sarah M Tiggelaar, Shang-Ying Hu, et al.
Gastroenterology|February 8, 2014
Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patientsQiang Gao, Ying-Jun Zhao, Xiao-Ying Wang, et al.
Cancer Medicine|December 21, 2016
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trialFeng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Journal of Translational Medicine|October 1, 2024
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumorsDao-Han Zhang, Chen Liang, Shu-Yang Hu, et al.
Pageof 122

Showing results (1191-1200 of 1,220) with videos related to

Sort By:
Pageof 122
EMBO Reports|March 2, 2018
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancerXiu-Fei Chen, Meng-Xin Tian, Ren-Qiang Sun, et al.
JAMA Oncology|December 30, 2020
Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical TrialJunji Zhang, Yuqian Zhao, Yi Dai, et al.
Environmental Microbiology|November 19, 2013
Halomonas sulfidaeris-dominated microbial community inhabits a 1.8 km-deep subsurface Cambrian Sandstone reservoirYiran Dong, Charu Gupta Kumar, Nicholas Chia, et al.
Clinical and Translational Medicine|May 13, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancerChen Liang, Mu Ye, Lei Yu, et al.
Hepatology (Baltimore, Md.)|January 6, 2015
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progressionJia-Bin Cai, Guo-Ming Shi, Zhao-Ru Dong, et al.
Cancer Medicine|July 16, 2019
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trialFeng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Cancer Epidemiology|March 2, 2012
A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in ChinaFang-Hui Zhao, Sarah M Tiggelaar, Shang-Ying Hu, et al.
Gastroenterology|February 8, 2014
Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patientsQiang Gao, Ying-Jun Zhao, Xiao-Ying Wang, et al.
Cancer Medicine|December 21, 2016
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trialFeng-Cai Zhu, Shang-Ying Hu, Ying Hong, et al.
Journal of Translational Medicine|October 1, 2024
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumorsDao-Han Zhang, Chen Liang, Shu-Yang Hu, et al.
Pageof 122